Skip to main content

Table 1 Summary of studies that met inclusion criteria – studied populations and accelerometer-specific characteristics of each study

From: A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies

Authors

Population

Number of participants

Duration of disease

Control group

Accelerometer device used

Duration of accelerometer data collection

Body site of accelerometer placement

Physical activity measurement

Identified associations between accelerometer-assessed physical activity and disease activity

Bachasson et al. [28]

Adult IIM cases

5 (DM = 1, IMNM = 3, ASS = 1)

Newly diagnosed

 

GENEActiv

14 days each month for 6 months

Wrist-worn

ENMO

Increasing ENMO followed decreasing CK and increasing SF-36 (no formal statistical test reported)

Stephens et al. [21]

JDM

15

Not reported

 

Actical accelerometer

7 days

Right hip

Time spent light, moderate or vigorous physical activity

Not reported

Mathiesen et al. [22]

JDM

31

Range 2–36 years

 

ActiGraph GT1M accelerometer

7 days

Not explicitly describeda

Counts per minute

Not reported

Pinto et al. [23]

JDM

19

Mean 7.6 years (SD 3.2)

Healthy controls (n = 19)

ActiGraph GT3X

7 days

Elastic belt at the waistline

Time spent light, moderate or vigorous physical activity

Longer disease duration was associated with more time spent in a sedentary state (p-value = 0.026)

Current glucocorticoid use was associated with more time spent in a moderate to vigorous physical activity state (p-value = < 0.001)

Pinto et al. [24]

JDM

19

Mean 7.6 years (SD 3.2)

JSLE (n = 20)

ActiGraph GT3X

7 days

Elastic belt at the waistline

Time spent light, moderate or vigorous physical activity

Not reported

Riisager et al. [25]

JDM

21

Median 3.4 years (range 1.4–10.3)

 

Sense Wear accelerometer

Two 3 day periods of data collection, 12 weeks apart

Armband on upper arm

Number of steps in 48 h period

Accelerometer-assessed physical activity improved from 16,412 to 21,079 steps per 48 h period following a 12 week exercise programme (p-value = 0.015)

Habers et al. [26]

JDM

26

Median 4.4 years (0.8–11.4)

Intervention (home-based exercise programme) group vs control group

Actical

7 days – carried out three or four times throughout the study

Not explicitly describeda

Time spent in inactive, light, moderate or vigorous physical activity

No change in accelerometer-assessed physical activity between intervention (treadmill and strength exercise programme) and control groups (p-values = > 0.05)

Berntsen et al. [27]

JDM

45

Mean 20.8 years (SD 11.9)

Healthy controls (n = 45)

Actigraph GT3X

8 days

Dominant hip

Time spent in inactive, light, moderate or vigorous physical activity. Counts per minute

Shorter mean daily time spent in moderate to vigorous physical activity in inactive JDM group, compared to active JDM group (p-value = < 0.01)

  1. aManufacturer recommends the device to be worn on the waist at the mid-axillary line
  2. IIM Idiopathic inflammatory myopathy, JDM Juvenile dermatomyositis, DM Dermatomyositis, IMNM Immune-mediated necrotising myopathy, ASS Anti-synthetase syndrome, SD Standard deviation, JSLE Juvenile systemic lupus erythematosus, CK Creatine kinase, SF-36 36 Item Short Form Survey, MMT-8 Manual muscle testing, ENMO Euclidean norm minus one